Google
 
Google

World Stem Cell Summit 2010

Tuesday, February 19, 2008

British Journal of Cancer - Table of Contents alert Volume 98 Issue 4

Sponsored By ABCAM

Providing cutting edge antibodies to researchers worldwide

Abcam's catalog http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuL0EW
of over 40,000 reagents includes research tools for immunology,
cancer,neuroscience, chromatin, stem cells, cardiovascular
and nuclear signaling.Browse Abcam's immunology range of over
8,800 products,read customer product reviews and
visit the immunology resource centre at
http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuM0EX .


British Journal of Cancer
19 February 2008, Volume 98, Issue 4
Table of Contents

Reviews

677 Targeting telomerase for cancer therapeutics

J W Shay and W N Keith

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuN0EY
_____________________________________________________________________

684 Clinical implications of mutational analysis in
gastrointestinal stromal tumours

A Hoeben, P Schöffski and M Debiec-Rychter

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuO0EZ
_____________________________________________________________________

Clinical Studies

689 Polymorphisms of inflammatory and metalloproteinase genes,
Helicobacter pylori infection and the risk of oesophageal
adenocarcinoma

M Früh, W Zhou, R Zhai, L Su, R S Heist, J C Wain, N S
Nishioka, T J Lynch, F A Shepherd, D C Christiani and G Liu

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuP0Ea
_____________________________________________________________________

693 Randomised phase II trial of irinotecan plus cisplatin vs
irinotecan, cisplatin plus etoposide repeated every 3
weeks in patients with extensive-disease small-cell lung
cancer

I Sekine, H Nokihara, K Takeda, Y Nishiwaki, K Nakagawa, H
Isobe, K Mori, K Matsui, N Saijo and T Tamura

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuQ0Eb
_____________________________________________________________________

697 Parenteral oestrogen in the treatment of prostate cancer: a
systematic review

G Norman, M E Dean, R E Langley, Z C Hodges, G Ritchie, M
K B Parmar, M R Sydes, P Abel and A J Eastwood

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuR0Ec
_____________________________________________________________________

708 Employment status and work-related difficulties in stomach
cancer survivors compared with the general population

M K Lee, K M Lee, J-M Bae, S Kim, Y-W Kim, K W Ryu, J H
Lee, J-H Noh, T-S Sohn, S-K Hong and Y H Yun

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuS0Ed
_____________________________________________________________________

716 A phase II study to determine the ability of gefitinib to
reverse fluoropyrimidine resistance in metastatic
colorectal cancer (the INFORM study)

J Stebbing, M Harrison, R Glynne-Jones, J Bridgewater and
D Propper

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuT0Ee
_____________________________________________________________________

720 A phase II randomised clinical trial comparing cisplatin,
paclitaxel and ifosfamide with cisplatin, paclitaxel and
epirubicin in newly diagnosed advanced epithelial ovarian
cancer: long-term survival analysis

R Fruscio, N Colombo, A A Lissoni, A Garbi, R Fossati, N
Ieda', V Torri and C Mangioni

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuU0Ef
_____________________________________________________________________

728 Risk for contralateral breast cancer among carriers of the
CHEK2[ast]1100delC mutation in the WECARE Study

L Mellemkjær, C Dahl, J H Olsen, L Bertelsen, P Guldberg,
J Christensen, A-L Børresen-Dale, M Stovall, B Langholz, L
Bernstein, C F Lynch, K E Malone, R W Haile, M Andersson,
D C Thomas, P Concannon, M Capanu, J D Boice Jr and J L
Bernstein

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuV0Eg
_____________________________________________________________________

734 High rates of breast conservation for large ductal and lobular
invasive carcinomas combining multimodality strategies

M A Bollet, A Savignoni, J-Y Pierga, M Lae, V Fourchotte,
Y M Kirova, R Dendale, F Campana, B Sigal-Zafrani, R
Salmon, A Fourquet and A Vincent-Salomon

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuW0Eh
_____________________________________________________________________

742 Prognostic significance of L-type amino acid transporter 1
expression in resectable stage I-III nonsmall cell lung
cancer

K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N
Sunaga, T Hisada, S Tanaka, T Ishizuka, Y Kanai, H Endou,
T Nakajima and M Mori

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuX0Ei
_____________________________________________________________________

Translational Therapeutics

749 Enhancement of the antitumor activity of ionising radiation by
nimotuzumab, a humanised monoclonal antibody to the
epidermal growth factor receptor, in non-small cell lung
cancer cell lines of differing epidermal growth factor
receptor status

Y Akashi, I Okamoto, T Iwasa, T Yoshida, M Suzuki, E
Hatashita, Y Yamada, T Satoh, M Fukuoka, K Ono and K
Nakagawa

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuY0Ej
_____________________________________________________________________

756 CD44+CD24- prostate cells are early cancer progenitor/stem
cells that provide a model for patients with poor prognosis

E M Hurt, B T Kawasaki, G J Klarmann, S B Thomas and W L
Farrar

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0BnuZ0Ek
_____________________________________________________________________

766 Collagenase-2 (matrix metalloproteinase-8) plays a protective
role in tongue cancer

J T Korpi, V Kervinen, H Mäklin, A Väänänen, M Lahtinen, E
Läärä, A Ristimäki, G Thomas, M Ylipalosaari, P Åström, C
Lopez-Otin, T Sorsa, S Kantola, E Pirilä and T Salo

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnua0Er
_____________________________________________________________________

776 Identification of biomarkers for the antiangiogenic and
antitumour activity of the superoxide dismutase 1 (SOD1)
inhibitor tetrathiomolybdate (ATN-224)

F Doñate, J C Juarez, M E Burnett, M M Manuia, X Guan, D E
Shaw, E L P Smith, C Timucin, M J Braunstein, O A Batuman
and A P Mazar

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnub0Es
_____________________________________________________________________

784 Immunisation with 'naïve' syngeneic dendritic cells protects
mice from tumour challenge

M J Grimshaw, K Papazisis, G Picco, H Bohnenkamp, T Noll,
J Taylor-Papadimitriou and J Burchell

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnuc0Et
_____________________________________________________________________

792 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel
natural product for prostate cancer therapy: activity in
vitro and in vivo and mechanisms of action

W Wang, H Wang, E R Rayburn, Y Zhao, D L Hill and R Zhang

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnud0Eu
_____________________________________________________________________

803 Regulation of apoptosis-inducing factor-mediated,
cisplatin-induced apoptosis by Akt

X Yang, M Fraser, M R Abedini, T Bai and B K Tsang

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnue0Ev
_____________________________________________________________________

809 Interactions between microenvironment and cancer cells in two
animal models of bone metastasis

S Blouin, M F Baslé and D Chappard

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnuf0Ew
_____________________________________________________________________

Molecular Diagnostics


816 MethCancerDB - aberrant DNA methylation in human cancer

M Lauss, I Visne, A Weinhaeusel, K Vierlinger, C Noehammer
and A Kriegner

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnug0Ex
_____________________________________________________________________

818 Utility of malignancy markers in fine-needle aspiration
cytology of thyroid nodules: comparison of Hector
Battifora mesothelial antigen-1, thyroid peroxidase and
dipeptidyl aminopeptidase IV

C de Micco, V Savchenko, R Giorgi, F Sebag and J-F Henry

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnuh0Ey
_____________________________________________________________________

824 SOX2 is frequently downregulated in gastric cancers and
inhibits cell growth through cell-cycle arrest and
apoptosis

T Otsubo, Y Akiyama, K Yanagihara and Y Yuasa

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnui0Ez
_____________________________________________________________________

832 Impacts of excision repair cross-complementing gene 1 (ERCC1),
dihydropyrimidine dehydrogenase, and epidermal growth
factor receptor on the outcomes of patients with advanced
gastric cancer

J Matsubara, T Nishina, Y Yamada, T Moriwaki, T Shimoda, T
Kajiwara, T E Nakajima, K Kato, T Hamaguchi, Y Shimada, Y
Okayama, T Oka and K Shirao

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnuj0E1
_____________________________________________________________________

Genetics and Genomics

840 Prospective surveillance of women with a family history of
breast cancer: auditing the risk threshold

E Anderson, J Berg, R Black, N Bradshaw, J Campbell, H
Carnaghan, R Cetnarkyj, S Drummond, R Davidson, J Dunlop,
A Fordyce, B Gibbons, D Goudie, H Gregory, S Holloway, M
Longmuir, L McLeish, V Murday, Z Miedzybrodska, D
Nicholson, P Pearson, M Porteous, M Reis, S Slater, K
Smith, E Smyth, L Snadden, M Steel, D Stirling, C Watt, C
Whyte and D Young

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnuk0E2
_____________________________________________________________________

845 Coexpression of EphB4 and ephrinB2 in tumour advancement of
ovarian cancers

S M Alam, J Fujimoto, I Jahan, E Sato and T Tamaya

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnul0E3
_____________________________________________________________________

Letters to the Editor

852 Missing ligand model in autologous stem cell transplantation

M Stern, M Paulussen, J Rischewski, A Tichelli and A
Gratwohl

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnum0E4
_____________________________________________________________________

854 Reply: Missing ligand model in autologous stem cell
transplantation

W Leung, R Handgretinger, V Turner and G A Hale

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnun0E5
_____________________________________________________________________

Book Review

855 Contemporary Issues in Cancer Imaging: Lung Cancer

N Navani and S M Janes

http://ealerts.nature.com/cgi-bin24/DM/y/ejGB0Xztnp0Hhi0Bnuo0E6
_____________________________________________________________________


======================================================================

You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

(c) Copyright 2008 Nature Publishing Group

======================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time